HPV16 Antibodies as Diagnostic and Prognostic Biomarkers in Pre-Invasive and Invasive Disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 20, 2017
app pub date -
Mar 19, 2015
filing date -
Mar 27, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Methods and systems for detection of HPV mediated cervical or oropharyneal cancer are provided. The methods include contacting a fluid sample from a patient with multiple antibodies to HPV16 early gene proteins and comparing patterns of HPV16 antibody bound to said early gene proteins with a control associated with cervical or oropharyneal cancer (FIG. 1).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully